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Background: Vector resistance in Uganda has threatened to
reverse the present gains in malaria control. To address the chal-
lenge of vector resistance, WHO recommends the distribution
of piperonyl butoxide (PBO) long lasting insecticide treated nets
(LLINs) which are more effective; however, the cost effectiveness
of their use is still unknown. Cost effectiveness studies are crucial
to help inform governments in resource poor setting on how best
to prioritize between the new PBO-LLINs and the Non PBO-LLINs.
This study therefore aimed to determine the cost effectiveness of
PBO-LLINs and the conventional Non PBO-LLINs in the reduction of
Malaria among children in Jinja district.
Methods and materials: A Markov model was used to simu-
late the sequence of malaria morbidity in a hypothetical Ugandan
cohort of children aged 2 years using an 8 year time horizon and
two-weeks cycle length. Model parameters were obtained using
data from the experts from Ministry of Health (MOH), malaria
consortium and published literature. The provider’s perspective
was used to explore the costs and health outcomes measured as
quality adjusted life years (QALYs). Incremental cost-effectiveness
ratios (ICERs) were calculated and sensitivity analyses conducted.
ICERs less than three times the GDP per capita ($604.4*3) and less
than once the GDP per capita ($604.04) were classified as cost-
effectiveness and very cost-effective respectively following WHO
guidelines.
Results: The unit cost of PBO-LLIN program was US$ 116 and
US$ 71 for Non-PBO LLIN program (incremental unit cost = US$ 45).
The unit QALYs gained under the PBO arm were US 26.9 QALYs and
25.6 QALYs under the Non-PBO (incremental QALYs = 1.3). In the
base case analysis, the ICER comparing PBO-LLIN to the non-PBO
LLIN was $ 34.22 per QALY gained. This indicates that the PBO-LLIN
were very cost effective as it was less than the Ugandan GDP per
capita (US$ 604.04).
Conclusion: This study showed that PBO-LLINs were very cost
effective compared to non-PBO-LLINs. However, cost-effectiveness
could be lost if the effectiveness of PBO-LLINs reduced. Efforts to
further optimize the effectiveness of PBO-LLINs through proper
usage would increase the cost-effectiveness of PBO-LLINs. How-
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Background: Mass chemotherapy is currently the recom-
mended approach for control of schistosomiasis. However, there is
concern that this might not be financially sustainable over extended
periods and the increasing drug pressure is likely to favor resistant
parasite genotypes. We formulated a local and easier to implement
alternative; porridge flour fortified with papaya seeds extracts
(UjiPlus®) as a potential antischistosoma compound and evaluated
it’s acceptability and efficacy.
Methods and materials: A total of 346 children aged 3–6
yrs. [x̃ = 4.5; IQR = 4–5] were enrolled. UjiPlus® was provided daily
through a school feeding program for 4 consecutive weeks. Stool
samples were collected from each child at baseline (week zero)
and follow-up (week 4) and subjected to Kato-Katz microscopic
examination for Schistosoma mansoni egg/s presence and infection
intensity by two independent microscopists.
Results: At baseline 294 participants provided a stool sample.
At follow-up (FU) 247 participants provided a stool sample, of these
52 had not provided a sample at baseline. Compliance data to
UjiPlus® was available for 237 children; 105(44.3%), 107(45.2%),
18(7.6%), 5(2.1%), and 2(0.8%) missed taking UjiPlus® for 0 days
(100% compliance), 1–3 days, 4–6 days, 7–9 days and 10 or more
days respectively. Reasons for non-compliance included absen-
teeism due to minor illnesses not related to UjiPlus® (n = 77),
truancy (n = 31), family related issues (n = 16); some participants
had been sent home to collect UjiPlus® cooking fuel fee (n = 9)
while some refused to take UjiPlus® due to stomach-ache (n = 3) or
diarrhoea (n = 1) caused by drinking the porridge. Side effects were
observed in 16 children, with 2 reporting 3 and 1 reporting 2 side
effects. These included Stomach-ache (n = 5), vomit (n = 4), cough
(n = 4), running nose (n = 3), diarrhea (n = 2), nausea (n = 2) and body
rush (n = 1). The overall prevalence of Schistosoma mansoni infec-
tions at baseline and follow-up was 39.8% vs. 30.4% [P = 0.022;
RR = 1.31; 95% CI (1.04–1.66)]. Among the infected mean egg counts
were 183.2 epg vs. 161.3 epg.
Conclusion: In these preliminary results, UjiPlus® was well
accepted and tolerated in the children population. UjiPlus® also
yielded a reduction in Schistosoma mansoni prevalence and infec-
tion intensity.
https://doi.org/10.1016/j.ijid.2020.09.800
